MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0026944
Boneym Pharmaceuticals Private Limited
Boneym Pharmaceuticals Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹36.03 Lakh
▲ 63% YoY
Net profit · FY 2025
₹59,947
Net margin 1.7%
EBITDA · FY 2025
₹85,547
EBITDA margin 2.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Boneym Pharmaceuticals Private Limited
Data last updated:
Boneym Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 17 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC340665. Its GSTIN is 10AAICB0748F1Z7 (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Manoj Kumar Shah and Jayanta Sarkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Mrs. Anita Rai W/O Mr. Bhushan Rai Flat No. 307 – E Pocket – C Mayur Vihar Ph, Ase – II, Delhi, India – 110091.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.03 Lakh, a growth of 63% compared to the previous year. For the same year it recorded a net profit of ₹59,947 (net margin 1.7%) and EBITDA of ₹85,547 (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.
Boneym Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0026944).
Company details
CIN U51909DL2018PTC340665
Registration Number 340665
Incorporation Date 17 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0026944
Key People
Manoj Kumar Shah Director Jayanta Sarkar Director Recognitions & Rankings of Boneym Pharmaceuticals
Contact details
Boneym Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Mrs. Anita Rai W/O Mr. Bhushan Rai Flat No. 307 – E Pocket – C Mayur Vihar Ph, Ase – II, Delhi, India – 110091
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Boneym Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Boneym Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Boneym Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Boneym Pharmaceuticals Private Limited, buy the company report.
Financials of Boneym Pharmaceuticals Private Limited
FY 2025 filings availableBoneym Pharmaceuticals Private Limited reported revenue of ₹36.03 Lakh (up 63% YoY) for FY 2025.
Revenue · FY 2025
₹36.03 Lakh ▲ 63%
Net profit · FY 2025
₹59,947 margin 1.7%
EBITDA · FY 2025
₹85,547 margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 59%
5 years · compounded
▲ 84%
Revenue has grown at a compounded annual rate (CAGR) of 41% over three years, including 63% growth in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹85,547 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59,947 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Boneym Pharmaceuticals Private Limited, buy the company report.
Board of directors of Boneym Pharmaceuticals Private Limited
Boneym Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Shah | Director | 20 Jul 2022 | 4 Years 3 Months | Current |
| Jayanta Sarkar | Director | 22 Aug 2019 | 7 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Boneym Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Boneym Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Boneym Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICB0748F1Z7 | Bihar | Active | 24 Oct 2019 |
To see the full GST registrations and return filing status of Boneym Pharmaceuticals Private Limited, buy the company report.
Recent activity
Boneym Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Chaitali Sarkar ceased to be Director on 22 Jul 2022.
AGM
Boneym Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Boneym Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Chaitali Sarkar ceased to be Director.
Appointed
Manoj Kumar Shah was appointed as Director.
Ceased
Sonali Sarkar ceased to be Director.
Appointed
Jayanta Sarkar was appointed as Director.
Incorporation
17 Oct 2018
Boneym Pharmaceuticals Private Limited was registered on 17 Oct 2018 with Roc Delhi I & aged 8 years 11 days as per MCA records.
Frequently asked questions
Boneym Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 17 October 2018 (8+ years old) and is registered under CIN U51909DL2018PTC340665.
Boneym Pharmaceuticals has 2 current directors:
- Manoj Kumar Shah - Director
- Jayanta Sarkar - Director
The latest financial statements of Boneym Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Boneym Pharmaceuticals is 10AAICB0748F1Z7, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Boneym Pharmaceuticals is U51909DL2018PTC340665. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Boneym Pharmaceuticals was incorporated on 17 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Chaitali Sarkar ceased to be Director on 22 Jul 2022. Manoj Kumar Shah was appointed as Director on 20 Jul 2022. Sonali Sarkar ceased to be Director on 24 Aug 2019. Boneym Pharmaceuticals has 4 board changes on record in total.
Yes, Boneym Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0026944).
The registered office of Boneym Pharmaceuticals is at CO Mrs. Anita Rai WO Mr. Bhushan Rai Flat No. 307 – E Pocket – C Mayur Vihar Ph, Ase – II, Delhi, India – 110091.
Boneym Pharmaceuticals operates in the trading industry, in the specialty segment.